Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.

China-Japan Friendship Hospital120 enrolled

Overview

This is an observational study in which patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.

This is an observational study covering mainland China, and patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Pulmonary Artery Sarcoma

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Computed tomography pulmonary angiography indicated that there were intraluminal defects * Malignant histopathology was sarcoma * Informed consent form was signed Exclusion Criteria: * Life expectancy was less than 3 months due to diseases other than pulmonary artery sarcoma * Expected inability to complete follow-up

Locations (1)

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China

RECRUITING

Outcomes

Primary Outcomes

Progression-free survival

Time to death or disease progression

Time frame: 36 months

Secondary Outcomes

Overall survival

Time to death

Time frame: 36 months

Postoperative survival

Time from surgery to death

Time frame: 36 months

Central Contacts

Wanmu Xie

CONTACT

+86 15611734410 xiewanmu@126.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.